CCCC

4.20

2.55% -0.11

Handel nachbörslich: 4.20

C 4 Therapeutics Inc (CCCC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$4.31

Offen:

$4.25

24-Stunden-Volumen:

1.24M

Relative Volume:

1.28

Marktkapitalisierung:

$296.12M

Einnahmen:

$20.76M

Nettoeinkommen (Verlust:

$-132.49M

KGV:

-1.4737

EPS:

-2.85

Netto-Cashflow:

$-108.55M

1W Leistung:

-28.57%

1M Leistung:

-33.86%

6M Leistung:

-26.06%

1J Leistung:

+132.04%

1-Tages-Spanne:

$3.879

$4.355

1-Wochen-Bereich:

$3.879

$5.89

52-Wochen-Spanne:

$1.06

$11.88

C 4 Therapeutics Inc Stock (CCCC) Company Profile

Firmenname

C 4 Therapeutics Inc

Sektor

Healthcare (1196)

Branche

Biotechnology (683)

Telefon

(617) 231-0700

Adresse

490 ARSENAL WAY, WATERTOWN

Mitarbeiter

145

Twitter

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

CCCC's Discussions on Twitter

Vergleichen Sie CCCC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CCCC	4.20	296.12M	20.76M	-132.49M	-108.55M	-2.85
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

C 4 Therapeutics Inc Stock (CCCC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-02-24	Hochstufung	Credit Suisse	Underperform → Neutral
2023-02-24	Herabstufung	JP Morgan	Neutral → Underweight
2022-11-04	Herabstufung	JP Morgan	Overweight → Neutral
2022-10-11	Eingeleitet	Morgan Stanley	Underweight
2022-04-28	Eingeleitet	Credit Suisse	Underperform
2022-04-11	Herabstufung	BofA Securities	Buy → Neutral
2022-03-10	Eingeleitet	JP Morgan	Overweight
2022-02-11	Fortgesetzt	BMO Capital Markets	Outperform
2022-02-10	Eingeleitet	Wells Fargo	Equal Weight
2021-11-23	Eingeleitet	BofA Securities	Buy
2021-10-14	Eingeleitet	SVB Leerink	Mkt Perform
2021-09-30	Eingeleitet	Stifel	Hold
2021-06-04	Eingeleitet	H.C. Wainwright	Buy
2021-03-31	Eingeleitet	BMO Capital Markets	Outperform
2020-10-28	Eingeleitet	UBS	Buy
2020-10-27	Eingeleitet	BMO Capital Markets	Outperform
2020-10-27	Eingeleitet	Jefferies	Buy

Alle ansehen

C 4 Therapeutics Inc Aktie (CCCC) Neueste Nachrichten

Nov 16, 2024

C4 Therapeutics, Inc. (NASDAQ:CCCC) Sees Large Drop in Short Interest - MarketBeat

Nov 16, 2024

Nov 15, 2024

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Nov 15, 2024

Orbimed Advisors LLC Increases Stake in C4 Therapeutics Inc - GuruFocus.com

Nov 15, 2024

C4 Therapeutics, Inc.'s (NASDAQ:CCCC) 33% Share Price Plunge Could Signal Some Risk - Simply Wall St

Nov 15, 2024

Nov 13, 2024

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 13, 2024

Nov 11, 2024

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 11, 2024

Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 11, 2024

Nov 08, 2024

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Nov 08, 2024

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Nov 08, 2024

Nov 06, 2024

C4 Therapeutics: Holding Fast To A Generous Valuation Heading Into An Important ASH Readout - Seeking Alpha

Nov 06, 2024

CCCCC4 Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 06, 2024

C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial - The Manila Times

Nov 06, 2024

C4 Therapeutics Launches Phase 1 Trial in China: $357M Cancer Drug Partnership Advances | CCCC Stock News - StockTitan

Nov 06, 2024

Nov 05, 2024

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 05, 2024

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Nov 05, 2024

C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin's Lymphoma At the American Society of Hematology Annual Meeting - Marketscreener.com

Nov 05, 2024

C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin's Lymphoma at the American Society of Hematology (ASH) Annual Meeting - The Manila Times

Nov 05, 2024

C4 Therapeutics' Cemsidomide Trial Data Selected for Key ASH Presentations in NHL, Myeloma | CCCC Stock News - StockTitan

Nov 05, 2024

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 05, 2024

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Nov 05, 2024

Nov 04, 2024

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Nov 04, 2024

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 04, 2024

Will C4 Therapeutics' Upcoming Multiple Myeloma And NHL Trial Results Drive Stock Recovery? - RTTNews

Nov 04, 2024

Nov 01, 2024

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 01, 2024

ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 01, 2024

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 01, 2024

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 01, 2024

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Marketscreener.com

Nov 01, 2024

C4 Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 01, 2024

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 01, 2024

C4 Therapeutics Advances in Protein Degradation Therapy - TipRanks

Nov 01, 2024

Oct 31, 2024